Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2022; 43(01): 047-051
DOI: 10.1055/s-0042-1742446
Review Article

Modern Radiation Oncology: From IMRT to Particle Therapy—Present Status and the Days to Come

Sarbani Ghosh Laskar 
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Sangeeta Kakoti
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

There has been tremendous technological development in the field of radiation oncology, mainly during the last few decades. Parallel advancements in imaging and accelerator technologies have contributed significantly to the same. Present-day radiation therapy is aimed at precision, in terms of physical accuracy of both its planning and delivery. This has been made possible by improvements in defining the target (use of various radiological and functional imaging modalities), advanced radiotherapy planning methods (intensity-modulated radiation therapy and recent emergence of particle therapy), and robust verification techniques (image-guided radiation therapy). These developments have enabled delivery of adequate tumoricidal doses conforming to the target, thereby improving disease control with reduced normal tissue toxicity in a wide range of malignancies. Elucidation of molecular pathways determining radioresistance or systemic effects of radiotherapy and strategies for therapeutic manipulation of the same are also being explored. Overall, we look forward to ensuring basic radiotherapy access to all patients, and precision radiation therapy to appropriate candidates (triaged by disease anatomy or biology and associated cost-effectiveness).

Keywords

evolution - IMRT - radiation oncology

Sources of Support

NA


Authors' Contributions

Both authors contributed equally to the work.




Publication History

Article published online:
15 February 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Brady LW, Mieszkalski G. Cancer cure with organ preservation using radiation therapy. Front Radiat Ther Oncol 1993; 27: 245-249
    CrossrefPubMedGoogle Scholar
  • 2 Smitt MC, McPeak EM, Donaldson SS. The advantages of three-dimensional conformal radiotherapy for treatment of childhood cancer. Radiat Res 1998; 150 (5, Suppl): S170-S177
    CrossrefPubMedGoogle Scholar
  • 3 Hanks GE, Hanlon AL, Schultheiss TE. et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998; 41 (03) 501-510
    CrossrefPubMedGoogle Scholar
  • 4 Takahashi S. Conformation radiotherapy. Rotation techniques as applied to radiography and radiotherapy of cancer. Acta Radiol Diagn (Stockh) Published online 1965; (Suppl. 242) 242, 1 +
    PubMedGoogle Scholar
  • 5 Brahme A, Roos JE, Lax I. Solution of an integral equation encountered in rotation therapy. Phys Med Biol 1982; 27 (10) 1221-1229
    CrossrefPubMedGoogle Scholar
  • 6 Kijewski PK, Chin LM, Bjärngard BE. Wedge-shaped dose distributions by computer-controlled collimator motion. Med Phys 1978; 5 (05) 426-429
    CrossrefPubMedGoogle Scholar
  • 7 Njeh CF. Tumor delineation: the weakest link in the search for accuracy in radiotherapy. J Med Phys 2008; 33 (04) 136-140
    CrossrefPubMedGoogle Scholar
  • 8 Schmidt MA, Payne GS. Radiotherapy planning using MRI. Phys Med Biol 2015; 60 (22) R323-R361
    CrossrefPubMedGoogle Scholar
  • 9 MacManus M, Nestle U, Rosenzweig KE. et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 2009; 91 (01) 85-94
    CrossrefPubMedGoogle Scholar
  • 10 Schinagl DA, Kaanders JH, Oyen WJ. From anatomical to biological target volumes: the role of PET in radiation treatment planning. Cancer Imaging 2006; 6: S107-S116
    CrossrefPubMedGoogle Scholar
  • 11 Suh JH, Saxton JP. Conventional radiation therapy for skull base tumors: an overview. Neurosurg Clin N Am 2000; 11 (04) 575-586
    CrossrefPubMedGoogle Scholar
  • 12 McDonald MW, Liu Y, Moore MG, Johnstone PAS. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol 2016; 11: 32 DOI: 10.1186/s13014-016-0600-3.
    CrossrefPubMedGoogle Scholar
  • 13 Peng G, Wang T, Yang KY. et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 2012; 104 (03) 286-293
    CrossrefPubMedGoogle Scholar
  • 14 Zhang B, Mo Z, Du W, Wang Y, Liu L, Wei Y. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis. Oral Oncol 2015; 51 (11) 1041-1046
    CrossrefPubMedGoogle Scholar
  • 15 Michalski JM, Moughan J, Purdy J. et al. Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG Oncology RTOG 0126 randomized clinical trial. JAMA Oncol 2018; 4 (06) e180039 DOI: 10.1001/jamaoncol.2018.0039.
    CrossrefPubMedGoogle Scholar
  • 16 Combs SE, Behnisch W, Kulozik AE, Huber PE, Debus J, Schulz-Ertner D. Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma. BMC Cancer 2007; 7: 177 DOI: 10.1186/1471-2407-7-177.
    CrossrefPubMedGoogle Scholar
  • 17 Bral S, Gevaert T, Linthout N. et al. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. Int J Radiat Oncol Biol Phys 2011; 80 (05) 1343-1349
    CrossrefPubMedGoogle Scholar
  • 18 Sheehan JP, Xu Z, Lobo MJ. External beam radiation therapy and stereotactic radiosurgery for pituitary adenomas. Neurosurg Clin N Am 2012; 23 (04) 571-586
    CrossrefPubMedGoogle Scholar
  • 19 Siva S, Louie AV, Warner A. et al. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: a report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Cancer 2018; 124 (05) 934-942
    CrossrefPubMedGoogle Scholar
  • 20 Palma DA, Olson R, Harrow S. et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol 2020; 38 (25) 2830-2838
    CrossrefPubMedGoogle Scholar
  • 21 Zhong J, Patel K, Switchenko J. et al. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Cancer 2017; 123 (18) 3486-3493
    CrossrefPubMedGoogle Scholar
  • 22 Dirix P, Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010; 11 (01) 85-91
    CrossrefPubMedGoogle Scholar
  • 23 Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS One 2018; 13 (07) e0200137 DOI: 10.1371/journal.pone.0200137.
    CrossrefPubMedGoogle Scholar
  • 24 Paumier A, Ghalibafian M, Gilmore J. et al. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2012; 82 (04) 1522-1527
    CrossrefPubMedGoogle Scholar
  • 25 Ercan T, Iğdem S, Alço G. et al. Dosimetric comparison of field in field intensity-modulated radiotherapy technique with conformal radiotherapy techniques in breast cancer. Jpn J Radiol 2010; 28 (04) 283-289
    CrossrefPubMedGoogle Scholar
  • 26 Brown PD, Gondi V, Pugh S. et al; for NRG Oncology. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol 2020; 38 (10) 1019-1029
    CrossrefPubMedGoogle Scholar
  • 27 Chopra S, Gupta S, Kannan S. et al. Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol 2021; 39 (33) 3682-3692
    CrossrefPubMedGoogle Scholar
  • 28 McNair HA, Adams EJ, Clark CH, Miles EA, Nutting CM. Implementation of IMRT in the radiotherapy department. Br J Radiol 2003; 76 (912) 850-856
    CrossrefPubMedGoogle Scholar
  • 29 Potters L, Gaspar LE, Kavanagh B. et al; American Society for Therapeutic Radiology and Oncology, American College of Radiology. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys 2010; 76 (02) 319-325
    CrossrefPubMedGoogle Scholar
  • 30 Wang D, Zhang Q, Eisenberg BL. et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of radiation therapy oncology group RTOG-0630 trial. J Clin Oncol 2015; 33 (20) 2231-2238
    CrossrefPubMedGoogle Scholar
  • 31 Ezzell LC, Hansen EK, Quivey JM, Xia P. Detection of treatment setup errors between two CT scans for patients with head and neck cancer. Med Phys 2007; 34 (08) 3233-3242
    CrossrefPubMedGoogle Scholar
  • 32 Castelli J, Simon A, Lafond C. et al. Adaptive radiotherapy for head and neck cancer. Acta Oncol 2018; 57 (10) 1284-1292
    CrossrefPubMedGoogle Scholar
  • 33 Finazzi T, Haasbeek CJA, Spoelstra FOB. et al. Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors. Int J Radiat Oncol Biol Phys 2020; 107 (02) 270-278
    CrossrefPubMedGoogle Scholar
  • 34 Keall PJ, Mageras GS, Balter JM. et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006; 33 (10) 3874-3900
    CrossrefPubMedGoogle Scholar
  • 35 Li X, Kitpanit S, Lee A. et al. Toxicity profiles and survival outcomes among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy. JAMA Netw Open 2021; 4 (06) e2113205 DOI: 10.1001/jamanetworkopen.2021.13205.
    CrossrefPubMedGoogle Scholar
  • 36 Li J, Dabaja B, Reed V. et al. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 2011; 81 (01) 167-174
    CrossrefPubMedGoogle Scholar
  • 37 Dabaja BS, Hoppe BS, Plastaras JP. et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood 2018; 132 (16) 1635-1646
    CrossrefPubMedGoogle Scholar
  • 38 Yock TI, Yeap BY, Ebb DH. et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol 2016; 17 (03) 287-298
    CrossrefPubMedGoogle Scholar
  • 39 Jhaveri J, Cheng E, Tian S. et al. Proton vs. photon radiation therapy for primary gliomas: an analysis of the national cancer data base. Front Oncol 2018; 8: 440 DOI: 10.3389/fonc.2018.00440.
    CrossrefPubMedGoogle Scholar
  • 40 Xi M, Xu C, Liao Z. et al. Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis. Int J Radiat Oncol Biol Phys 2017; 99 (03) 667-676
    CrossrefPubMedGoogle Scholar
  • 41 Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002; 54 (03) 824-829
    CrossrefPubMedGoogle Scholar
  • 42 Lu VM, O'Connor KP, Mahajan A, Carlson ML, Van Gompel JJ. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes. J Neurooncol 2020; 147 (03) 503-513
    CrossrefPubMedGoogle Scholar
  • 43 von Essen CF. Radiation enhancement of metastasis: a review. Clin Exp Metastasis 1991; 9 (02) 77-104
    CrossrefPubMedGoogle Scholar
  • 44 Lin AJ, Roach M, Bradley J, Robinson C. Combining stereotactic body radiation therapy with immunotherapy: current data and future directions. Transl Lung Cancer Res 2019; 8 (01) 107-115
    CrossrefPubMedGoogle Scholar